InVivoMAb anti-mouse BTLA (CD272)

Bekiaris V, Šedý JR, Macauley MG, et al. The inhibitory receptor BTLA controls γδ T cell homeostasis and inflammatory responses. Immunity. 2013,39(6):1082-1094. doi: 10.1016/j.immuni.2013.10.017

Steinberg MW, Huang Y, Wang-Zhu Y, et al. BTLA interaction with HVEM expressed on CD8(+) T cells promotes survival and memory generation in response to a bacterial infection. PLoS One. 2013,8(10):e77992. doi: 10.1371/journal.pone.0077992

Nakagomi D, Suzuki K, Hosokawa J, et al. Therapeutic potential of B and T lymphocyte attenuator expressed on CD8+ T cells for contact hypersensitivity. J Invest Dermatol. 2013,133(3):702-711. doi: 10.1038/jid.2012.396

Tewalt EF, Cohen JN, Rouhani SJ, et al. Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells. Blood. 2012,120(24):4772-82. doi: 10.1182/blood-2012-04-427013

Lepenies B, Pfeffer K, Hurchla MA, et al. Ligation of B and T lymphocyte attenuator prevents the genesis of experimental cerebral malaria. J Immunol. 2007,179(6):4093-100.